Clindamycin hydrochloride monohydrate

Product Category:Pharmaceutical raw materials

Cas.NO:58207-19-5

Quality standard: ChP/USP/EP
Registered trademark: North of Anhui Province
Packaging: 20kg/drum
 Domestic and international registration:

 

China NMPA	CDE Registration no.: Y20190007894 Original drug approval number: SFDA approval numberH20103316
America FDA	DMF register DMF No.: 32342

 

【English name】Clindamycin Hydrochloride 
【Chinese pinyin】Yansuan Kelinmeisu
   [chemical name] 6 - (1-methyl-trans-4-propyl-l-2-pyrrolidine formylamino) - 1-thio-7 (s) - chloro-6,7,8-trideoxy-l-su-a-d-galactopyranoside hydrochloride
【Molecular formula】C₁₈H₃₃ClN₂O₅S·HCl  
【Molecular weight】461.44
【Appearance】white crystalline powder.
【Antibacterial action and application】 this product is applicable to moderate and severe infections caused by Streptococcus, Staphylococcus and anaerobic bacteria (including Bacteroides fragilis, Clostridium perfringens, actinomycetes, etc.), such as aspiration pneumonia, empyema, lung abscess, osteomyelitis, abdominal infection, pelvic infection and sepsis. It can be used for injection, capsule, ointment, gel, liniment and other formulations. It is suitable for the following infectious diseases caused by Gram positive bacteria and anaerobic bacteria, such as tonsillitis, suppurative otitis media, acute and chronic bronchitis, pneumonia, skin and soft tissue infection, urinary tract infection, female pelvic and genital infection, oral infection, etc. Osteomyelitis and infection after gynecological surgery.